Specialty Pharmacy

GLUT1 inhibitors could be a potential therapeutic target for the squamous subtype of cancer.

Society for Integrative Oncology releases updated clinical guidelines on integrative breast cancer treatments.

Tocilizumab (Actemra) is the first drug approved to treat giant cell arteritis.

Leader and follower cells depend on each other for survival and invasion.

Top news of the day from across the health care landscape.

Sheila Arquette, RPh, discusses optimal patient support programs in specialty pharmacy.

Surgeries that address colorectal cancer, ulcerative colitis, Crohn's disease, mechanical bowel obstruction and recurrent diverticulitis are often a necessity.

A how-to guide for pharmacy school students interested in pursuing a career in specialty pharmacy.

A cancer diagnosis can cause up to a 3.5% reduction in earnings for men and up to 6% for women.

Ceritinib (Zykadia) approved to treat anaplastic lymphoma kinase-positive metastatic non-small cell lung cancer.

Carboplatin plus birinapant effective against high-grade serious ovarian cancer.

Fampyra significantly improved walking and enhanced quality of life in patients with multiple sclerosis.

Top news of the day from across the health care landscape.

Patient genotypes of in both hepatitis C and advanced cirrhosis may help predict outcomes with direct-acting antiviral drugs.

Imaging technology highlights cancerous features of a breast tumor.

Top articles of the week from The American Journal of Pharmacy Benefits.

Study will assess improvements in mobility and changes in disability in patients with MS.

Early microbial changes may identify patients most likely to achieve and maintain treatment response.

Novel strategy prolongs immune system defense against HIV.

Novel combination may improve treatment options for castration resistant prostate cancer.

New diagnoses of squamous cell carcinoma increased 263% and basal cell carcinoma increased 145%.

Scientists override tumor growth effects of PTEN deletion.

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings, and more. Our Week in Review is a can't miss for the busy pharmacy professional.

Top articles of the week from Specialty Pharmacy Times.

Epoetin alfa biosimilar has indications in cancer, HIV, and chronic kidney disease, among other conditions.

This is the first recommendation for a proposed erythropoiesis-stimulating agent biosimilar.

Scientists project combining prevention programs could avert up to 40,000 HIV infections over 20 years among injection drug users.

Upcoming trial of Opdivo harnesses the immune system to target mesothelioma.

Collaboration is part of a citywide plan to ensure patients with HIV receive care and to reduce the number of new HIV transmissions.

As the prevalence of diabetes continues to rise, the development of safer and more efficient therapeutics is increasing in importance.